BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1951859)

  • 41. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
    Kura K; Hardwick RJ; Truscott JE; Toor J; Hollingsworth TD; Anderson RM
    Parasit Vectors; 2020 Nov; 13(1):554. PubMed ID: 33203467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.
    Augusto G; Magnussen P; Kristensen TK; Appleton CC; Vennervald BJ
    Parasitology; 2009 Nov; 136(13):1771-9. PubMed ID: 19490727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
    Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of some aspects of cell mediated immune response in bilharzial children on a field level.
    el-Hawey AM; Massoud AM; el-Rakieby A; Royzeik MS; Nassar MO
    J Egypt Soc Parasitol; 1991 Aug; 21(2):411-6. PubMed ID: 1908498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the crayfish Procambarus clarkii on Schistosoma haematobium transmission in Kenya.
    Mkoji GM; Hofkin BV; Kuris AM; Stewart-Oaten A; Mungai BN; Kihara JH; Mungai F; Yundu J; Mbui J; Rashid JR; Kariuki CH; Ouma JH; Koech DK; Loker ES
    Am J Trop Med Hyg; 1999 Nov; 61(5):751-9. PubMed ID: 10586907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection status and risk factors associated with urinary schistosomiasis among school-going children in the Ndumo area of uMkhanyakude District in KwaZulu-Natal, South Africa two years post-treatment.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    Int J Infect Dis; 2018 Jun; 71():100-106. PubMed ID: 29679769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B; Coulibaly JT; Hatz C; Keiser J
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experiences with mass chemotherapy in the control of schistosomiasis in Mali.
    Brinkmann UK; Werler C; Traoré M; Doumbia S; Diarra A
    Trop Med Parasitol; 1988 Jun; 39(2):167-74. PubMed ID: 3140359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of mass chemotherapy and piped water on numbers of Schistosoma haematobium and prevalence in Bulinus globosus in Kwale, Kenya.
    Noda S; Shimada M; Sato K; Ouma JH; Thiongo FW; Muhoho ND; Sato A; Aoki Y
    Am J Trop Med Hyg; 1988 May; 38(3):487-95. PubMed ID: 3152776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of borehole wells on water utilization in Schistosoma haematobium endemic communities in Coast Province, Kenya.
    el Kholy H; Arap Siongok TK; Koech D; Sturrock RF; Houser H; King CH; Mahmoud AA
    Am J Trop Med Hyg; 1989 Aug; 41(2):212-9. PubMed ID: 2505626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anemia and growth retardation associated with Schistosoma haematobium infection in Mali: a possible subtle impact of a neglected tropical disease.
    Stecher CW; Sacko M; Madsen H; Wilson S; Wejse C; Keita AD; Landouré A; Traoré MS; Kallestrup P; Petersen E; Vennervald B
    Trans R Soc Trop Med Hyg; 2017 Apr; 111(4):144-153. PubMed ID: 28673023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
    Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
    J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt.
    Talaat M; Miller FD
    Am J Trop Med Hyg; 1998 Oct; 59(4):546-50. PubMed ID: 9790428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment.
    Kihara JH; Njagi EN; Kenya EU; Mwanje MT; Odek AE; van Dam G; Kahama AI; Ouma JH
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1024-30. PubMed ID: 19647844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of praziquantel efficacy at 40 mg/kg and 60 mg/kg in treating Schistosoma haematobium infection among schoolchildren in the Ingwavuma area, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    S Afr Med J; 2020 Jul; 110(7):657-660. PubMed ID: 32880343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasonography of ureteric abnormalities induced by Schistosoma haematobium infection before and after praziquantel treatment.
    Kardorff R; Traoré M; Doehring-Schwerdtfeger E; Vester U; Ehrich JH
    Br J Urol; 1994 Dec; 74(6):703-9. PubMed ID: 7827837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
    N'Goran EK; Gnaka HN; Tanner M; Utzinger J
    Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metrifonate in the control of urinary schistosomiasis in Zanzibar.
    Mgeni AF; Kisumku UM; McCullough FS; Dixon H; Yoon SS; Mott KE
    Bull World Health Organ; 1990; 68(6):721-30. PubMed ID: 2127381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term effects of single-dose metrifonate on the control of urinary schistosomiasis in an endemic area.
    Mason PR; Tswana SA; Jenks P; Priddy CE
    J Trop Med Hyg; 1991 Jun; 94(3):180-3. PubMed ID: 1904945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost and effectiveness of different approaches to schistosomiasis control in Africa.
    Korte R; Schmidt-Ehry B; Kielmann AA; Brinkmann UK
    Trop Med Parasitol; 1986 Jun; 37(2):149-52. PubMed ID: 3092332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.